Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

July 4, 2019

Study Completion Date

September 27, 2019

Conditions

Healthy

Interventions

DRUG

NVP-1805-R1

1 tablet, multiple oral dosing

DRUG

NVP-1805-R2

1 tablet, multiple oral dosing

DRUG

NVP-1805-R1 and NVP-1805-R2

NVP-1805-R1,1 tablet and NVP-1805-R2, 1 tablet, co-administration, multiple oral dosing

Trial Locations (1)

Navipharm, Suwon